Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

Latest in relapsed and refractory multiple myeloma

Prof Heinz Ludwig, Prof Wee Joo Chng and Prof James Chim
Latest in relapsed and refractory multiple myeloma ( Prof Heinz Ludwig, Prof Wee Joo Chng and Prof James Chim )
25 Jun 2017

Front-line combinations in multiple myeloma: Highlights from EHA 2017

Prof Joy Ho and Prof Je-Jung Lee
Front-line combinations in multiple myeloma: Highlights from EHA 2017 ( Prof Joy Ho and Prof Je-Jung Lee )
25 Jun 2017

Latest maintenance strategies in multiple myeloma

Prof Guillermo Ruiz-Arguelles and Prof McCarthy
Latest maintenance strategies in multiple myeloma ( Prof Guillermo Ruiz-Arguelles and Prof McCarthy )
25 Jun 2017

Denosumab or zoledronic acid for bone disease in multiple myeloma

Prof Evangelos Terpos - University of Athens School of Medicine, Athens, Greece
Denosumab or zoledronic acid for bone disease in multiple myeloma ( Prof Evangelos Terpos - University of Athens School of Medicine, Athens, Greece )
25 Jun 2017

Extended followup indicates daratumumab with bortezomib and dexamethasone for relapsed MM

Prof Katja Weisel - University of Tübingen, Tübingen, Germany
Extended followup indicates daratumumab with bortezomib and dexamethasone for relapsed MM ( Prof Katja Weisel - University of Tübingen, Tübingen, Germany )
24 Jun 2017

Phase Ib/II study of nivolumab in combination with azacytidine in patients with relapsed AML

Prof Naval Daver - MD Anderson Cancer Center, Houston, USA
Phase Ib/II study of nivolumab in combination with azacytidine in patients with relapsed AML ( Prof Naval Daver - MD Anderson Cancer Center, Houston, USA )
24 Jun 2017

Interim analysis of the JULIET study

Prof Gilles Salles - Université Claude Bernard, Lyon, France
Interim analysis of the JULIET study ( Prof Gilles Salles - Université Claude Bernard, Lyon, France )
24 Jun 2017

ZUMA 1: CD19 CAR T cells for refractory NHL

Dr Yi Lin, Mayo Clinic - Rochester, MN, USA
ZUMA 1: CD19 CAR T cells for refractory NHL ( Dr Yi Lin, Mayo Clinic - Rochester, MN, USA )
24 Jun 2017

Diverse T lymphocyte population fights leukaemia more effectively

Dr Michaela Kotrova - University Hospital Schleswig-Holstein, Kiel, Germany
Diverse T lymphocyte population fights leukaemia more effectively ( Dr Michaela Kotrova - University Hospital Schleswig-Holstein, Kiel, Germany )
23 Jun 2017

Personalised medicine for rare cancers

Prof Paolo Casali - Università degli Studi di Milano, Milan, Italy
Personalised medicine for rare cancers ( Prof Paolo Casali - Università degli Studi di Milano, Milan, Italy )
19 Jun 2017

T-VEC and checkpoint therapy for melanoma

Prof Robert Andtbacka - Huntsman Cancer Institute, Salt Lake City, USA
T-VEC and checkpoint therapy for melanoma ( Prof Robert Andtbacka - Huntsman Cancer Institute, Salt Lake City, USA )
5 Jun 2017

Treating advanced melanoma with ipilimumab and HF10

Prof Robert Andtbacka - Huntsman Cancer Institute, Salt Lake City, USA
Treating advanced melanoma with ipilimumab and HF10 ( Prof Robert Andtbacka - Huntsman Cancer Institute, Salt Lake City, USA )
5 Jun 2017

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation